The Pharmaceutical Journal
Vol 274 No 7332 p43
15 January 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Diabetes vaccine trial to begin

Researchers at the University of Bristol and King’s College London have received funding to start human trials of a vaccine for type-1 diabetes. The vaccine is based on a peptide immunotherapy technique that prevents the destruction of pancreatic cells and has already been successfully tested in animals.